These IDH-mutant astrocytomas can be stratified solely by CNV level with thresholds of approximately 310–465 megabase pairs (Mbp) (~ 10–15% of the total genome) separating patient outcomes [23, 28, 32]. This evidence concerns the gene IDH2 and astrocytoma (excluding glioblastoma).